Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Dicerna Pharmaceuticals aggregated by PharmaCompass.com.

    Client Virtual Booth

    DICERNA PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Dicerna Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    33 Hayden Avenue Lexington, MA 02421
    Telephone
    Telephone
    (617) 621-8097
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://dicerna.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/dicerna-pharmaceuticals-inc.
    Twitter
    Twitter
    https://twitter.com/DicernaPharma?ref

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Novo Nordisk turns RNA attention to cardio disease in new pact
    Novo Nordisk turns RNA attention to cardio disease in new pact

    https://www.fiercebiotech.com/biotech/novo-nordisk-turns-rna-attention-cardio-disease-eleven-therapeutics-pact

    James Waldron FIERCE BIOTECH
    17 Jul 2023
    Share Share
    Novo Nordisk Completes Acquisition of Dicerna Pharmaceuticals
    Novo Nordisk Completes Acquisition of Dicerna Pharmaceuticals

    https://www.businesswire.com/news/home/20211227005121/en

    BUSINESSWIRE
    28 Dec 2021
    Share Share
    HSR Act Waiting Period Expires for Novo Nordisk Tender Offer to Acquire Dicerna
    HSR Act Waiting Period Expires for Novo Nordisk Tender Offer to Acquire Dicerna

    https://www.businesswire.com/news/home/20211225005009/en

    BUSINESSWIRE
    25 Dec 2021
    Share Share
    Ampio Pharmaceuticals CEO passes baton to a new board member; & more
    Ampio Pharmaceuticals CEO passes baton to a new board member; & more

    https://endpts.com/taking-a-leave-of-absence-ampio-pharmaceuticals-ceo-passes-baton-to-a-new-board-member-axel-hoos-cancer-biotech-lands-a-cfo/

    Alex Hoffmann ENDPTS
    24 Nov 2021
    Share Share
    Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna
    Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna

    https://www.fiercebiotech.com/biotech/novo-nordisk-bets-big-rnai-paying-3-3b-to-buy-dicerna

    N.P. Taylor FIERCEBIOTECH
    19 Nov 2021
    Share Share
    Novartis weighs Alnylam buy with Roche stake sale cash: report
    Novartis weighs Alnylam buy with Roche stake sale cash: report

    https://www.fiercepharma.com/pharma/where-will-novartis-spend-21b-from-roche-stake-sale-alnylam-could-be-one-report

    Angus Liu FIERCEPHARMA
    19 Nov 2021
    Share Share
    Dicerna Presents Data From Phase 1 Trial of Belcesiran at AASLD 2021
    Dicerna Presents Data From Phase 1 Trial of Belcesiran at AASLD 2021

    https://www.businesswire.com/news/home/20211112005405/en

    BUSINESSWIRE
    12 Nov 2021
    Share Share
    Dicerna Announces Two Targets Meet Preclinical Proof of Principle Criteria in Neurodegeneration and Pain Under Global Research Collaboration and Licensing Agreement With Lilly
    Dicerna Announces Two Targets Meet Preclinical Proof of Principle Criteria in Neurodegeneration and Pain Under Global Research Collaboration and Licensing Agreement With Lilly

    https://investors.dicerna.com/news-releases/news-release-details/dicerna-announces-two-targets-meet-preclinical-proof-principle

    PRESS RELEASE
    12 Nov 2021
    Share Share
    Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021
    Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021

    https://investors.dicerna.com/news-releases/news-release-details/dicerna-presents-data-phase-1-trial-belcesiran-american

    PRESS RELEASE
    12 Nov 2021
    Share Share
    Dicerna Announces Q3 2021 Financial Results, Provides Business Update
    Dicerna Announces Q3 2021 Financial Results, Provides Business Update

    https://www.businesswire.com/news/home/20211109005512/en

    BUSINESSWIRE
    09 Nov 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    famar-2024-07-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search